COMBINATION OF LAQUINIMOD AND PRIDOPIDINE TO TREAT MULTIPLE SCLEROSIS

摘要

This invention provides a method of treating a subject afflicted with multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising administering to the subject laquinimod as an add-on to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and pridopidine for treating a subject afflicted with MS or presenting CIS. This invention also provides laquinimod for use as an add-on therapy or in combination with pridopidine in treating a subject afflicted with MS or presenting CIS. This invention further provides use of laquinimod and pridopidine in the preparation of a combination for treating a subject afflicted with MS or presenting CIS.